RESEARCH TRIANGLE PARK, N.C., March 12, 2018 /PRNewswire/ -- Global Lyme Diagnostics (GLD) is excited to announce that Dr. Darin Ingels has joined GLD's Scientific Advisory Board.
GLD's sole mission is to service the dire, unmet needs of our global Lyme community with a new diagnostic solution specific to Lyme Disease that is grounded in science and designed to significantly decrease the number of patients being misdiagnosed.
Dr. Ingels, a Bastyr University alumnus, is a licensed naturopathic physician in the State of Connecticut and a licensed Doctor of Naturopathic Medicine in the State of California, where he maintains practices in both states. He is Board Certified in Integrated Pediatrics through the American Association of Integrative Medicine and is a Fellow with the American Academy of Environmental Medicine. Dr. Ingels has numerous publications, international lectures and 30 years of experience in the healthcare field. His work includes a chapter on allergy desensitization for autistic children in "Cutting Edge Therapies for Autism", and The Lyme Solution: A 5-Part Plan to Fight The Inflammatory Autoimmune Response And Beat Lyme Disease, a book to be launched on March 27, 2018.
Dr. Ingels' practice focuses on environmental medicine with emphasis on Lyme disease, autism, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS and PANDAS) and chronic immune dysfunction; including allergies, asthma, recurrent or persistent infections and other genetic or acquired immune problems. He uses diet, nutrients, herbs, homeopathy, and immunotherapy along with conventional medicine to help his patients achieve better health.
"I am pleased to be part of Global Lyme Diagnostics Scientific Advisory Board," says Dr. Ingels. "As a former medical technologist, I understand the importance of having reliable lab testing, especially with Lyme disease as Lyme testing has historically had poor sensitivity. I have had Lyme disease myself and have treated thousands of Lyme patients, so am happy that I can help contribute my experience as patient, clinician and microbiologist to help further our understanding of Lyme disease and help develop better diagnostic testing."
"We are very excited to have Dr. Ingels join our Scientific Advisory Board. His clinical advice will be extremely valuable in furthering GLD's science to help the global Lyme community," stated Mickey Ramchandani, CEO of GLD. "Misdiagnosis is a core issue, as Lyme Disease can masquerade as many things – juvenile arthritis, fibromyalgia, chronic fatigue syndrome, and a host of other diseases. We are passionate about providing a diagnostic solution that decreases the misdiagnosis of Lyme Disease."
Dr. Darin Ingels is available for media interviews upon request. Please contact Dustin Starnes at (919) 341-1271 or email@example.com.
About Global Lyme Diagnostics
The GLD Lyme test can be requested by clinicians at physician kit request. Patients that would like to request a kit to take to their clinicians can do so here. Note: The GLD Test is not yet available for PA or NY residents. More information about GLD, including the science behind the new test is available at https://glymedx.com.
SOURCE Global Lyme Diagnostics